Current guidelines recommend transdermal delivery of testosterone for post-menopausal women seeking treatment for hypoactive sexual desire disorder. Medherant’s TEPI patch has been developed to fill ...
Two governmental agencies will analyse domestic manufacturing of transdermal oestrogen patches, shortages are currently ...